DermTech Dirección
Dirección controles de criterios 0/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Bret Christensen
Chief Executive Officer (CEO)
US$1.9m
Compensación total
Porcentaje del salario del CEO | 20.2% |
Permanencia del CEO | less than a year |
Participación del CEO | n/a |
Permanencia media de la dirección | 1.8yrs |
Promedio de permanencia en la Junta Directiva | 2.6yrs |
Actualizaciones recientes de la dirección
Recent updates
We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate
Mar 02Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%
Mar 02Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price
Dec 28Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky
Sep 18Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?
Jun 14Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023
May 10DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%
May 06We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate
Jan 16Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)
Nov 08Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?
Oct 11DermTech grants stock options
Oct 11Diving Into DermTech
Sep 01Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80
Aug 10DermTech: Approaching An All Or Nothing Moment
Jun 13We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate
Jun 04DermTech - Taking A Second Look At The Growth Thesis
Mar 31DermTech: Adoption Headwinds And Earnings Misses
Dec 23Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth
Dec 02DermTech - Game Changer, Set To Become The Leader In Skin Diagnostics
Sep 15We Think DermTech (NASDAQ:DMTK) Can Afford To Drive Business Growth
Sep 03DermTech: Transforming The Melanoma Diagnosis Landscape
Aug 31DermTech: Becoming More Appealing, Despite Nosebleed Valuation
Aug 09DermTech appoints former Myriad Genetics executive as new chief medical officer
Jun 16We're Not Very Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate
Jun 05DermTech initiated buy at BTIG on the potential of PLA test
May 03DermTech rises 18% on report Cigna covering early melanoma detection test
Apr 27Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Dec 31 2023 | US$2m | US$389k | -US$101m |
Compensación vs. Mercado: La compensación total de Bret($USD1.93M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD670.12K).
Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Bret con los resultados de la empresa.
CEO
Bret Christensen (52 yo)
less than a year
Permanencia
US$1,928,967
Compensación
Mr. Bret Christensen serves as Chief Executive Officer, President and Director at DermTech, Inc. since May 08, 2023. He serves as Director of Axena Health, Inc. Mr. Christensen had been Chief Commercial Of...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
President | less than a year | US$1.93m | sin datos | |
CFO, Treasurer & Secretary | 4.7yrs | US$934.85k | 0.79% $ 172.8k | |
General Counsel | 3.3yrs | US$818.76k | 0.17% $ 36.2k | |
Chief Information Officer | 1.6yrs | sin datos | sin datos | |
Senior Director of Investor Relations | no data | sin datos | sin datos | |
Chief Compliance Officer | 1.8yrs | sin datos | sin datos | |
Chief Medical Affairs Officer | 7.3yrs | US$480.83k | sin datos | |
Chief Medical Officer | 2.9yrs | sin datos | sin datos | |
Senior Vice President of Research & Development | 1.8yrs | sin datos | sin datos | |
Chief Commercial Officer | less than a year | sin datos | sin datos |
1.8yrs
Permanencia media
52yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de DMTK no se considera experimentado ( 1.8 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
President | less than a year | US$1.93m | sin datos | |
Independent Director | 4.8yrs | US$149.64k | 0.29% $ 62.2k | |
Independent Director | 1.8yrs | US$136.64k | 0.013% $ 2.8k | |
Independent Chairman of the Board | 7.8yrs | US$188.64k | 0.35% $ 77.1k | |
Independent Director | 1.8yrs | US$139.64k | 0.057% $ 12.5k | |
Independent Director | 4.8yrs | US$156.64k | 0.20% $ 43.5k | |
Independent Director | 2.6yrs | US$134.64k | 0.089% $ 19.5k |
2.6yrs
Permanencia media
56yo
Promedio de edad
Junta con experiencia: La junta directiva de DMTK no se considera experimentada (2.5 años de permanencia promedio), lo que sugiere una nueva junta directiva.